The Effect of Serum Ferritin in irAE

Abroad (travel likely)Recruiting

Conditions

Immune-related Adverse Event · Malignant Solid Tumors · Acute Leukemia · Serum Ferritin

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Liang Liu, MD.) · liangcoh@163.com · 86-22-23340123
Contact: Study coordinator (Xiubao Ren, MD. PhD.) · renxiubao@tjmuch.com · 86-22-23340123

Study leads

Xiubao Ren, M.D, Ph.D
Principal Investigator
ianjin Medical University Cancer Institute and Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma

Melanoma · Immune-related Adverse Event · Immune Checkpoint Inhibitor

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China · Shenzhen, China

Brodalumab in the Treatment of Immune-Related Adverse Events

Breast Cancer · Esophageal Cancer · Kidney Cancer

Abroad (travel likely)RecruitingPHASE1

New York, United States

Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis

Pneumonitis · Immune-related Adverse Event

Abroad (travel likely)RecruitingPHASE2

Calgary, Canada

Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge

Immune-Related Adverse Events

Abroad (travel likely)Recruiting

Beijing, China